Coronavirus Disease-2019 and Implications on the Liver
Overview
Authors
Affiliations
The coronavirus disease-2019 (COVID-19) pandemic has had a large impact on patients with chronic liver disease (CLD) and liver transplantation (LT) recipients. Patients with advanced CLD are at a significantly increased risk of poor outcomes in the setting of severe acute respiratory syndrome coronavirus 2 infection. The pandemic has also considerably altered the management and care that is provided to patients with CLD, pre-LT patients, and LT recipients. Vaccination against COVID-19 protects patients with CLD and LT recipients from adverse outcomes and is safe in these patients; however, vaccine efficacy may be reduced in LT recipients and other immunosuppressed patients.
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?.
Michalak A, Lach T, Szczygiel K, Cichoz-Lach H Int J Mol Sci. 2024; 25(4).
PMID: 38396888 PMC: 10888568. DOI: 10.3390/ijms25042212.
Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?.
John N, Ibrahim B, Ebaid M, Saab S Hepat Med. 2023; 15:185-193.
PMID: 37850074 PMC: 10578169. DOI: 10.2147/HMER.S371507.
Liver Damage and COVID-19: At Least a "Two-Hit" Story in Systematic Review.
Montori M, Baroni G, Santori P, Di Giampaolo C, Ponziani F, Abenavoli L Curr Issues Mol Biol. 2023; 45(4):3035-3047.
PMID: 37185723 PMC: 10136465. DOI: 10.3390/cimb45040199.
The Latest Cellular and Molecular Mechanisms of COVID-19 on Non-Lung Organs.
Askari H, Rabiei F, Lohrasbi F, Ghadir S, Ghasemi-Kasman M Brain Sci. 2023; 13(3).
PMID: 36979225 PMC: 10046222. DOI: 10.3390/brainsci13030415.